Boston Financial Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.86M | Buy |
32,997
+1,389
| +4% | +$255K | 0.18% | 93 |
|
|
2024
Q3 | $6.24M | Buy |
31,608
+1,284
| +4% | +$240K | 0.19% | 89 |
|
|
2024
Q2 | $5.2M | Sell |
30,324
-537
| -2% | -$89K | 0.17% | 99 |
|
|
2024
Q1 | $5.62M | Sell |
30,861
-20
| -0.1% | -$3.45K | 0.18% | 96 |
|
|
2023
Q4 | $4.79M | Buy |
30,881
+5,926
| +24% | +$864K | 0.16% | 99 |
|
|
2023
Q3 | $3.72M | Sell |
24,955
-257
| -1% | -$37.7K | 0.14% | 104 |
|
|
2023
Q2 | $3.4M | Sell |
25,212
-675
| -3% | -$99K | 0.12% | 113 |
|
|
2023
Q1 | $4.13M | Sell |
25,887
-3,683
| -12% | -$563K | 0.16% | 102 |
|
|
2022
Q4 | $4.78M | Buy |
29,570
+244
| +0.8% | +$37.4K | 0.19% | 92 |
|
|
2022
Q3 | $3.94M | Buy |
29,326
+1,653
| +6% | +$237K | 0.17% | 91 |
|
|
2022
Q2 | $4.24M | Buy |
27,673
+892
| +3% | +$136K | 0.18% | 87 |
|
|
2022
Q1 | $4.34M | Buy |
26,781
+372
| +1% | +$54K | 0.16% | 90 |
|
|
2021
Q4 | $3.58M | Buy |
26,409
+922
| +4% | +$109K | 0.13% | 89 |
|
|
2021
Q3 | $2.75M | Buy |
25,487
+566
| +2% | +$64.7K | 0.11% | 92 |
|
|
2021
Q2 | $2.81M | Sell |
24,921
-2,025
| -8% | -$228K | 0.11% | 91 |
|
|
2021
Q1 | $2.92M | Sell |
26,946
-3,552
| -12% | -$380K | 0.13% | 85 |
|
|
2020
Q4 | $3.27M | Sell |
30,498
-5,146
| -14% | -$495K | 0.15% | 82 |
|
|
2020
Q3 | $3.12M | Sell |
35,644
-1,287
| -3% | -$121K | 0.15% | 83 |
|
|
2020
Q2 | $3.63M | Sell |
36,931
-253
| -0.7% | -$22.3K | 0.2% | 80 |
|
|
2020
Q1 | $2.83M | Sell |
37,184
-6,365
| -15% | -$542K | 0.18% | 83 |
|
|
2019
Q4 | $3.86M | Sell |
43,549
-3,756
| -8% | -$312K | 0.21% | 90 |
|
|
2019
Q3 | $3.58M | Sell |
47,305
-4,204
| -8% | -$288K | 0.2% | 94 |
|
|
2019
Q2 | $3.75M | Sell |
51,509
-7,554
| -13% | -$594K | 0.22% | 93 |
|
|
2019
Q1 | $4.76M | Sell |
59,063
-4,304
| -7% | -$352K | 0.29% | 89 |
|
|
2018
Q4 | $5.84M | Sell |
63,367
-7,185
| -10% | -$632K | 0.4% | 77 |
|
|
2018
Q3 | $6.67M | Buy |
70,552
+4,345
| +7% | +$412K | 0.39% | 84 |
|
|
2018
Q2 | $6.13M | Sell |
66,207
-29,666
| -31% | -$2.9M | 0.41% | 81 |
|
|
2018
Q1 | $9.07M | Sell |
95,873
-8,005
| -8% | -$879K | 0.62% | 59 |
|
|
2017
Q4 | $10M | Sell |
103,878
-2,309
| -2% | -$218K | 0.67% | 57 |
|
|
2017
Q3 | $9.44M | Sell |
106,187
-15,302
| -13% | -$1.16M | 0.67% | 56 |
|
|
2017
Q2 | $8.81M | Sell |
121,489
-4,381
| -3% | -$295K | 0.63% | 59 |
|
|
2017
Q1 | $8.2M | Sell |
125,870
-3,270
| -3% | -$206K | 0.61% | 61 |
|
|
2016
Q4 | $8.09M | Sell |
129,140
-8,001
| -6% | -$488K | 0.64% | 55 |
|
|
2016
Q3 | $8.65M | Sell |
137,141
-14,643
| -10% | -$948K | 0.71% | 44 |
|
|
2016
Q2 | $9.4M | Sell |
151,784
-37,167
| -20% | -$2.26M | 0.77% | 35 |
|
|
2016
Q1 | $10.8M | Sell |
188,951
-38,721
| -17% | -$2.16M | 1.62% | 12 |
|
|
2015
Q4 | $13.5M | Sell |
227,672
-17,342
| -7% | -$999K | 1.93% | 5 |
|
|
2015
Q3 | $13.3M | Sell |
245,014
-3,436
| -1% | -$224K | 1.89% | 6 |
|
|
2015
Q2 | $16.7M | Sell |
248,450
-11,843
| -5% | -$773K | 2.15% | 4 |
|
|
2015
Q1 | $15.2M | Buy |
260,293
+8,956
| +4% | +$541K | 1.91% | 5 |
|
|
2014
Q4 | $16.4M | Sell |
251,337
-18,061
| -7% | -$1.14M | 2.07% | 4 |
|
|
2014
Q3 | $15.6M | Sell |
269,398
-4,570
| -2% | -$254K | 2.04% | 4 |
|
|
2014
Q2 | $15.5M | Sell |
273,968
-39,540
| -13% | -$2.07M | 2.04% | 4 |
|
|
2014
Q1 | $16.1M | Sell |
313,508
-3,990
| -1% | -$202K | 2.16% | 4 |
|
|
2013
Q4 | $16.8M | Buy |
317,498
+9,105
| +3% | +$447K | 2.3% | 3 |
|
|
2013
Q3 | $13.8M | Sell |
308,393
-7,764
| -2% | -$344K | 2.07% | 6 |
|
|
2013
Q2 | $13.1M | Buy |
+316,157
| New | +$13.8M | 2.02% | 6 |
|
Other funds holding ABBV
Boston Financial Management's ABBV Position: Q4 2024 in Review
Boston Financial Management increased its AbbVie (ABBV) stake by 4.4% in Q4 2024, buying an estimated $255K and bringing the position to 32,997 shares worth $5.86M. The position accounts for 0.18% of the portfolio, ranked #93.
Boston Financial Management first reported a position in ABBV in Q2 2013 and has held it in 47 quarters since. The position peaked at $16.8M in Q4 2013. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Boston Financial Management held 32,997 shares of AbbVie worth $5.86M as of Q4 2024.
- Boston Financial Management bought 1,389 AbbVie shares in Q4 2024, an estimated $255K.
- AbbVie made up 0.18% of Boston Financial Management's portfolio in Q4 2024, its #93 holding.
- Boston Financial Management first reported a position in AbbVie in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's AbbVie position peaked at $16.8M in Q4 2013.
- 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.